Private Equity: Swiss financial investor Ufenau succeeds in important deal
The mid-market investor Bridgepoint is taking over the stake in Altano, the world's largest equine medicine group, according to information from Handelsblatt. The deal is of particular importance for Ufenau.
Ufenau Capital is selling its stake in Altano Group, a leading global equine medicine company, to British investment firm Bridgepoint. The deal values Altano at around €600 million and makes Bridgepoint the majority shareholder. Altano operates 110 clinics and practices worldwide, employing nearly 1000 veterinarians, and generates €350 million in annual revenue and €50-60 million in EBITDA. Bridgepoint plans to further internationalize Altano, focusing on growth markets in the US and Australia.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
